Sharescart Research Club logo

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹189 Cr.
Stock P/E
22.5
P/B
2.5
Current Price
₹5
Book Value
₹ 2
Face Value
1
52W High
₹9.8
52W Low
₹ 3.8
Dividend Yield
0%

MK Proteins Overview

Business

MK Proteins Ltd. operates in the edible oil sector in India. The company is primarily involved in the manufacturing, refining, and processing of various edible oils. Its core business model involves procuring raw edible oils (such as crude palm oil, soybean oil, mustard oil, etc.) or oilseeds, processing them through refining and fractionation to produce refined edible oils suitable for direct human consumption, and then packaging and distributing them to consumers and industrial clients. The company makes money through the sales of these processed and refined oils, earning margins on the value addition from refining and distribution.

Revenue Mix

While specific revenue breakdowns are not publicly detailed for MKPL, a company in the edible oil sector typically generates revenue from:

Refined Edible Oils: Sale of various types of refined oils (e.g., refined soy oil, palm oil, groundnut oil, mustard oil) in different pack sizes (pouches, bottles, tins) for household and institutional use.

Crude Edible Oils/Trading: Potentially, some revenue might come from trading in crude edible oils or supplying semi-processed oils to other manufacturers.

By-products: Sale of by-products like oil cakes (often used as animal feed) generated during the oil extraction process.

Without specific data, it is generally assumed that refined edible oils constitute the dominant portion of revenue for a company like MK Proteins.

Industry

The Indian edible oil industry is large, diverse, and highly competitive, characterized by both organized players and a significant unorganized sector. India is one of the world's largest consumers and importers of edible oils, with a substantial portion of its demand met through imports (primarily palm oil, soybean oil, and sunflower oil). The industry structure includes large integrated players with nationwide brands, mid-sized regional players, and numerous small refiners. MK Proteins Ltd. likely positions itself as a regional or mid-sized player within this fragmented landscape, focusing on specific geographies or product types, rather than being a dominant national leader. Competition is fierce, primarily on price, distribution reach, and brand recognition in the consumer segment.

MOAT

For a company like MK Proteins operating in a largely commoditized market, developing a strong competitive moat can be challenging. Potential advantages, if present, could include:

Efficient Operations & Cost Leadership: Ability to procure raw materials at competitive prices, operate refining facilities efficiently, and manage logistics to maintain low production costs.

Established Distribution Network: A robust network for distributing products to retail channels and institutional buyers within its target regions.

Brand Recognition (Regional): While difficult to achieve nationally for mid-sized players, a strong regional brand presence and customer loyalty could offer some advantage.

Relationships with Suppliers: Long-standing relationships with key domestic and international suppliers of crude oils or oilseeds.

Without specific details, it is difficult to ascertain a strong, durable moat. Many edible oil companies face intense price competition, making sustained competitive advantage difficult.

Growth Drivers

Increasing Per Capita Consumption: Rising disposable incomes and urbanization in India are expected to drive up the per capita consumption of edible oils.

Population Growth: India's growing population provides a continuous increase in overall demand for essential food items like edible oils.

Shift from Unorganized to Organized: A gradual shift in consumer preference towards branded, quality-assured edible oils from the unorganized sector benefits organized players.

Expansion of Food Processing Industry: Growth in the packaged food and HoReCa (Hotel, Restaurant, Catering) segments increases demand for bulk edible oils.

Diversification into Value-Added Products: Potential for growth by introducing fortified oils, specialized oils, or other value-added products.

Risks

Raw Material Price Volatility: Prices of crude edible oils and oilseeds are subject to global supply-demand dynamics, geopolitical events, and climate change, leading to significant fluctuations and impacting margins.

Government Policies & Import Duties: Changes in import duties on crude and refined edible oils by the Indian government directly impact the company's cost structure and competitiveness.

Intense Competition: The fragmented nature of the industry and presence of large national and multinational players lead to aggressive pricing and marketing strategies.

Foreign Exchange Fluctuations: Given India's reliance on imported edible oils, currency fluctuations (especially USD-INR) can impact procurement costs.

Climate Change & Agricultural Output: Adverse weather conditions can affect domestic oilseed production, potentially leading to higher raw material costs.

Health Concerns & Regulatory Scrutiny: Increasing consumer awareness about health and stricter food safety regulations could necessitate investments in quality control and compliance.

Management & Ownership

MK Proteins Ltd., typical of many Indian listed companies, is likely promoter-driven. The promoters and their families usually hold a significant stake, providing a long-term vision and commitment to the business. The quality of management is critical for navigating the volatile edible oil market, requiring expertise in procurement, refining technology, logistics, and market dynamics. Specific details regarding the current management team's experience, track record, or corporate governance practices are not publicly detailed here, but promoter involvement is a key characteristic of such companies in India.

Outlook

MK Proteins operates in an essential sector with consistent demand, driven by India's large and growing population. The shift towards branded and quality-assured edible oils presents a tailwind for organized players. However, the industry remains highly susceptible to external factors such as volatile global raw material prices, government import policies, and intense domestic competition. The company's future performance will largely depend on its ability to efficiently manage raw material procurement, optimize operational costs, expand its distribution network, and maintain product quality and brand perception within its target markets to mitigate margin pressures inherent in a commoditized industry.

MK Proteins Share Price

Live · BSE / NSE · Inception: 2012
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

MK Proteins Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 14 69 87 57 34 39 137 115 32 90
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 14 69 87 57 34 40 137 115 33 90
Total Expenditure 13 65 78 54 31 38 133 109 31 87
Operating Profit 1 4 9 4 2 2 5 6 1 2
Interest 0 0 0 0 0 0 1 1 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 3 8 3 2 2 4 5 1 2
Provision for Tax 0 1 2 1 1 0 1 1 0 1
Profit After Tax 0 2 6 2 2 1 3 4 1 1
Adjustments 0 0 0 0 0 0 -0 0 -0 0
Profit After Adjustments 0 2 6 2 2 1 3 4 1 1
Adjusted Earnings Per Share 0 0.1 0.2 0.1 0 0 0.1 0.1 0 0

MK Proteins Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 123 145 165 172 157 194 311 256 315 245 268 374
Other Income 0 0 0 0 0 0 0 0 1 0 0 0
Total Income 123 145 165 172 157 194 311 256 316 246 268 375
Total Expenditure 119 141 160 166 152 189 295 240 298 229 255 360
Operating Profit 4 4 5 6 5 5 16 16 18 17 13 14
Interest 2 2 2 2 2 2 1 1 2 1 1 2
Depreciation 1 1 1 1 1 1 1 1 1 1 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 2 2 2 2 14 14 15 15 11 12
Provision for Tax 0 0 1 1 1 1 4 4 4 4 3 3
Profit After Tax 1 1 1 1 2 2 10 10 11 11 8 9
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 1 1 1 2 2 10 10 11 11 8 9
Adjusted Earnings Per Share 0 0 0 0 0 0 0.3 0.3 0.3 0.3 0.2 0.2

MK Proteins Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 3 3 4 15 17 19 29 40 50 61 69
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 7 8 12 12 2 4 4 3 3 0 1
Other Non-Current Liabilities 0 0 0 0 -0 -0 -0 -0 1 1 1
Total Current Liabilities 25 28 30 29 29 34 34 44 52 36 61
Total Liabilities 35 39 47 56 47 56 67 86 105 98 132
Fixed Assets 6 7 7 6 4 3 2 3 3 3 4
Other Non-Current Assets 0 0 0 0 0 0 0 0 1 7 8
Total Current Assets 29 32 39 50 42 53 64 82 101 88 120
Total Assets 35 39 47 56 47 56 67 86 105 98 132

MK Proteins Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 11 -4 -4 -12 6 -4 6 -10 -6 32 -16
Cash Flow from Investing Activities -0 -2 -1 -0 0 0 -0 -2 0 -6 -1
Cash Flow from Financing Activities -10 6 5 12 -7 4 -5 12 6 -27 18
Net Cash Inflow / Outflow -0 0 -0 0 -0 0 -0 0 0 0 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

MK Proteins Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.03 0.03 0.04 0.04 0.04 0.05 0.28 0.27 0.29 0.3 0.22
CEPS(Rs) 0.06 0.07 0.09 0.07 0.08 0.08 0.3 0.3 0.31 0.31 0.23
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.1 0.13 0.16 0.41 0.46 0.5 0.78 1.06 1.33 1.63 1.85
Core EBITDA Margin(%) 3.38 2.92 3 3.21 3.2 2.48 5.14 6.06 5.4 6.78 4.66
EBIT Margin(%) 2.84 2.33 2.3 2.56 2.46 2.04 4.87 5.83 5.35 6.74 4.71
Pre Tax Margin(%) 0.99 0.72 0.92 1.28 1.46 1.26 4.6 5.49 4.75 6.29 4.27
PAT Margin (%) 0.68 0.5 0.6 0.83 1.05 0.94 3.34 3.98 3.47 4.56 3.13
Cash Profit Margin (%) 1.22 1.12 1.33 1.54 1.83 1.54 3.63 4.34 3.73 4.78 3.26
ROA(%) 2.48 1.94 2.3 2.78 3.18 3.51 16.83 13.32 11.45 11.04 7.3
ROE(%) 39.43 24.9 27.1 14.62 10.07 10.07 43.03 29.54 24.44 20.21 12.87
ROCE(%) 13.53 13.06 11.82 10.57 8.42 8.54 29.13 22.82 19.78 18.99 13.46
Receivable days 17.24 20.25 16.87 24.54 34.18 19.13 17.69 35.56 26.19 14.57 3.39
Inventory Days 60.14 52.77 59.12 67.28 69.12 64.25 44.99 62.38 69.99 111.73 129.74
Payable days 22.28 27.84 21.28 16.85 9.8 6.29 7.51 10.5 6.29 13.74 23.45
PER(x) 0 0 0 23.49 18.9 16.39 3.19 7.84 0 33.08 27
Price/Book(x) 0 0 0 2.16 1.81 1.57 1.13 2.02 0 6.07 3.26
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.17 0.18 0.2 0.39 0.37 0.31 0.19 0.46 0.18 1.59 0.99
EV/Core EBITDA(x) 4.87 6.19 6.68 11.78 11.25 11.73 3.63 7.36 3.22 22.8 20.39
Net Sales Growth(%) 1.23 17.46 13.67 4.32 -8.66 23.82 60.26 -17.75 23.05 -22.06 9.08
EBIT Growth(%) 42.3 -3.81 12.51 15.91 -12.24 2.61 282.21 -1.43 13.11 -1.86 -23.88
PAT Growth(%) 69.26 -13.67 36.54 44.67 15.18 10.57 471.79 -1.97 7.37 2.54 -25.1
EPS Growth(%) 68.97 -13.7 36.49 -5.94 15.26 10.5 471.9 -1.99 7.37 2.54 -25.11
Debt/Equity(x) 7.76 8.03 7.66 2.13 1.53 1.61 0.86 0.93 0.89 0.31 0.54
Current Ratio(x) 1.14 1.15 1.3 1.73 1.48 1.57 1.92 1.88 1.94 2.44 1.98
Quick Ratio(x) 0.28 0.42 0.19 0.69 0.46 0.41 0.79 0.74 0.57 0.24 0.15
Interest Cover(x) 1.54 1.45 1.66 2 2.45 2.61 18.37 16.82 8.9 15.02 10.84
Total Debt/Mcap(x) 0 0 0 0.98 0.84 1.03 0.76 0.46 0 0.05 0.17

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +9% +2% +7% +8%
Operating Profit CAGR -24% -7% +21% +13%
PAT CAGR -27% -7% +32% +23%
Share Price CAGR -29% -41% +42%
ROE Average +13% +19% +26% +23%
ROCE Average +13% +17% +21% +15%

MK Proteins Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 74.82 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 25.18 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 74.8274.8274.8274.8274.8274.8274.8274.8274.8274.82
FII 00.020.020000000
DII 0000000000
Public 25.1825.1825.1825.1825.1825.1825.1825.1825.1825.18
Others 0000000000
Total 100100100100100100100100100100

MK Proteins Peer Comparison

Edible Oil Edit Columns

MK Proteins Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

MK Proteins Pros & Cons

Pros

  • Company has delivered good profit growth of 31% CAGR over last 5 years

Cons

  • Debtor days have increased from 13.74 to 23.45days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp